Lenvatinib, sold under the brand name Lenvima among others, is an anti-cancer medication for the treatment of certain kinds of thyroid cancer and for other...
11 KB (934 words) - 11:38, 21 October 2024
baricitinib, cabozantinib, dasatinib, neratinib, eltrombopag, ibrutinib, lenvatinib, palbociclib, regorafenib, tofacitinib, and trelagliptin. BEACON Medicare...
5 KB (232 words) - 10:23, 8 March 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
25 KB (1,825 words) - 05:46, 16 December 2024
after resection, or to relieve pain from bone metastasis. Sorafenib and lenvatinib are approved for advanced metastatic thyroid cancer. Numerous agents are...
60 KB (5,331 words) - 22:54, 31 December 2024
breast cancer Iomeron (iomeprol) - Non-ionic contrast medium Lenvima (lenvatinib) - Thyroid Cancer or Kidney Cancer Leqembi (lecanemab) - Alzheimer's disease...
12 KB (887 words) - 23:00, 12 November 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
70 KB (6,131 words) - 08:28, 27 December 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
26 KB (2,420 words) - 02:40, 26 September 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
93 KB (8,733 words) - 03:33, 16 December 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
43 KB (4,657 words) - 07:27, 28 November 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
73 KB (6,458 words) - 08:26, 6 December 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
64 KB (7,432 words) - 08:21, 28 October 2024
triple-negative breast cancer Avalglucosidase alfa Genzyme late-onset Pompe disease Lenvatinib Eisai Inc advanced renal cell carcinoma, used in combination with pembrolizumab...
42 KB (240 words) - 05:05, 7 January 2025
everolimus and was approved by the FDA as a second-line treatment in 2016. Lenvatinib in combination with everolimus was approved in 2016 for patients who have...
56 KB (5,187 words) - 16:09, 5 January 2025
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
149 KB (15,719 words) - 16:46, 9 December 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
11 KB (666 words) - 00:54, 27 December 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
15 KB (976 words) - 17:10, 20 October 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
73 KB (6,489 words) - 08:56, 21 December 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
9 KB (1,066 words) - 13:45, 13 August 2023
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
10 KB (1,179 words) - 18:31, 8 August 2024
Vandetanib L01EX05 Regorafenib L01EX06 Masitinib L01EX07 Cabozantinib L01EX08 Lenvatinib L01EX09 Nintedanib L01EX10 Midostaurin L01EX11 Quizartinib L01EX12 Larotrectinib...
13 KB (935 words) - 04:36, 23 December 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
121 KB (13,818 words) - 07:04, 26 December 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
60 KB (6,879 words) - 14:26, 16 July 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
36 KB (3,929 words) - 18:22, 21 September 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
42 KB (3,937 words) - 11:44, 15 November 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
10 KB (1,131 words) - 19:14, 31 March 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
13 KB (1,177 words) - 01:44, 4 November 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
15 KB (1,122 words) - 15:16, 4 August 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
14 KB (1,689 words) - 01:31, 19 August 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
29 KB (2,696 words) - 14:16, 27 July 2024
Kinase inhibitors: Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
22 KB (1,993 words) - 23:37, 23 March 2024